Selection of potentially metastatic subpopulations expressing c-erbB-2 from breast cancer tissue by use of an extravasation model

American Journal of Pathology

Volumn 153, Issue 6, 1998, Pages 1797-1806

  Roetger, Antje ^a   Merschjann, Anja ^a   Dittmar, Thomas ^b   Jackisch, Christian ^a   Barnekow, Angelika ^a   Brandt, Burkhard ^a,c  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

^c Institute of Clinical Chemistry   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; HERMES ANTIGEN; INTEGRIN;

ARTICLE; BREAST CANCER; CANCER INVASION; CANCER STAGING; CELL SUBPOPULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; METASTASIS; ONCOGENE C ERB; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031770794     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65694-5     Document Type: Article

References (33)

1. Fidler IJ, Hart IR: Biological diversity in metastatic neoplasms: origins and implications. Science 1982, 217:998-1003
2. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991, 64:327-336
3. Schlimok G, Funke I, Holzmann B, Göttlinger G, Schmidt G, Häuser H, Swierkot S, Warnecke HH, Schneider B, Koprowski H, Riethmüller G: Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies. Proc Natl Acad Sci USA 1987, 84:8672-8676
4. Coussens L, Yang-Feng TL, Liao Y-C, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U, Levinson A, Ullrich A: Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with Neu oncogene. Science 1985, 230:1132-1139
5. Nilsen-Hamilton M (editor): Growth Factors and Development. London, Academic Press, 1990
6. Press MF, Cordon-Cardo C, Slamon DJ: Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. Oncogene 1990, 5:953-962
7. Brandt BH, Vogt U, Schlotter CM, Jackisch C, Werkmeister R, Thomas M, von Eiff M, Bosse U, Assmann G, Zänker KS: Prognostic relevance of aberrations in the erbB oncogenes from breast, ovarian, oral and lung cancers: double-differential polymerase chain reaction (ddPCR) for clinical diagnosis. Gene 1995, 159:35-42
8. Yu D, Hung M-C: The HER-2/neu gene in human cancers. Molecular Basis of Oncology. Edited by Freireich EJ, Stass SA. Cambridge, Blackwell Science, 1995, pp 131-162
9. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987, 235:177-182
10. Thor AD, Schwartz LH, Koerner FC, Edgerton SM, Skates SJ, Yin S, McKenzie SJ, Panicali DL, Marks PJ, Fingert HJ: Analysis of c-erbB-2 expression in breast carcinomas with clinical follow-up. Cancer Res 1989, 49:7147-7152
11. Wriqht C, Angus B, Nicholson S, Sainsbury JR, Cairns J, Gullick WJ, Kelly P, Harris AL, Horne CH: Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer. Cancer Res 1989, 49:2087-2090
12. Yu D, Wang S-S, Dulski K, Tsai C-M, Nicolson GL, Hung M-C: c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties. Cancer Res 1994, 54:3260-3266
13. Tan M, Yao J, Yu D: Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. Cancer Res 1997, 57:1199-1205
14. Verbeek BS, Adriaansen-Slot SS, Vroom TM, Beckers T, Rijksen G: Overexpression of EGFR and c-erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts. FEBS Lett 1998, 425:145-150
15. Falcioni R, Antonini A, Nisticò P, Di Stefano S, Crescenzi M, Natali PG, Sacchi A: α6β4 and α6β1 integrins associate with ErbB-2 in human carcinoma cell lines. Exp Cell Res 1997, 236:76-85
16. Brandt B, Roetger A, Heidi S, Jackisch C, Lellé RJ, Assmann G, Zänker KS: Isolation of blood-borne epithelial derived c-erbB-2 oncoprotein positive clustered cells from the peripheral blood of breast cancer patients. Int J Cancer 1998, 76:824-828
17. Gimbrone MA Jr. Cotran RS, Folkman J: Human vascular endothelial cells in culture: growth and DNA synthesis. J Cell Biol 1977, 60:673-684
18. Friedl P, Tatje D, Czapla R: An optimized culture medium for human endothelial cells from human umbilical veins. Cytotechnology 1989, 2:171-179
19. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Kozlowski JM, McEwan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987, 47:3239-3245
20. Riesenberg R, Oberneder R, Kriegmair M, Epp M, Bitzer U, Hofstetter A, Braun S, Riethmüller G, Pantel K: Immunocytochemical double staining of cytokeratin and prostate specific antigen in individual prostatic tumor cells. Histochemistry 1993, 99:61-66
21. HER2 causes transformation and tumorigenesis of NIH 3T3 cells. Proc Natl Acad Sci USA 1987, 84: 7159-7163
22. Stetler-Stevenson WG, Aznavoorian S, Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993, 9:541-573
23. Sy MS, Liu D, Schiavone R, Ma J, Mori H, Guo Y: Interactions between CD44 and hyaluronic acid: their role in tumor growth and metastasis. Curr Top Microbiol Immunol 1996, 213:129-153
24. Imhof BA, Piali L, Gisler RH, Dunon D: Involvement of α6 and αv integrins in metastasis. Curr Top Microbiol Immunol 1996, 213:195-203
25. Brooks PC, Strömblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA: Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 1996, 85:683-693
26. Fidler IJ: Critical factors in the biology of human cancer metastasis: twenty-eighth G. H. A. Clowes Memorial Award Lecture. Cancer Res 1990, 50:6130-6138
27. DiFiore PP, Pierce JH, Kraus MH, Segatto O, King CR, Aaronson SA: erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science 1990, 237:178-182
28. Di Marco E, Pierce J, Knickley C, DiFiore P: Transformation of NIH 3T3 cells by overexpression of the normal coding sequence of the rat neu gene. Mol Cell Biol 1990, 10:3247-3252
29. Dougall WC, Qian X, Peterson NC, Miller MJ, Samanta A, Green MI: The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies. Oncogene 1994, 9:2109-2123
30. Friedl P, Noble PB, Walton PA, Laird DW, Chauwin PJ, Tabah RJ, Black M, Zänker KS: Migration of coordinated cell clusters in mesenchymal and epithelial cancer explants in vitro. Cancer Res. 1995, 55:4557-4560
31. Gusterson B, Gelber R, Goldhirsch A, Price K, Save-Soderberg J, Anbazhagan R, Styles J, Rudenstam C-M, Golouh R, Reed R, Martinez-Tello F, Tiltman A, Torhorst J, Grigolato P, Bettelheim R, Neville A, Burki K, Castiglione M, Collins J, Lindtner J, Senn H-J: Prognostic importance of c-erbB-2 expression in breast cancer. J Clin Oncol 1992, 10:1049-1056
32. Pantel K, Schlimok G, Braun S, Kutter D, Lindemann F, Schaller G, Funke I, Izbicki JR, Riethmüller G: Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst 1993, 85:1419-1423
33. Niehans GA, Singleton PS, Dykovski D, Kiang D: Stability of Her-2/neu expression over time and at multiple metastatic sites. J Natl Cancer Inst 1993, 85:1235-1240